Author:
Boyarskikh Ulyana,Pintus Sergey,Mandrik Nikita,Stelmashenko Daria,Kiselev Ilya,Evshin Ivan,Sharipov Ruslan,Stegmaier Philip,Kolpakov Fedor,Filipenko Maxim,Kel Alexander
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Reference34 articles.
1. Ray-Coquard I, Blay JY, Italiano A, Le Cesne A, Penel N, Zhi J, Heil F, Rueger R, Graves B, Ding M, Geho D, Middleton SA, Vassilev LT, Nichols GL. Bui BN effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. Lancet Oncol. 2012;13(11):1133–40.
2. Burgess A, Chia KM, Haupt S, Thomas D, Haupt Y, Lim E. Clinical overview of MDM2/X-targeted therapies. Front Oncol. 2016;6:7.
https://doi.org/10.3389/fonc.2016.00007
. eCollection 2016. Review
3. De Anta J.M., Mayo de Las Casas C., Real F.X., Mayol X. Unmasking the mechanisms of colon cancer cell resistance to methotrexate: cell drug sensitivity is dependent on a transiently adaptive mechanism Gastroentérologie Clinique et Biologique 2002 , Vol 26, N° 4 - avril p. 399 Doi : GCB-04-2002-26-4-0399-8320-101019-ART34.
4. Esfandiari A, Hawthorne TA, Nakjang S, Lunec J. Chemical inhibition of wild-type p53-induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 potentiates the sensitivity to MDM2 inhibitors in a p53-dependent manner. Mol Cancer Ther. 2016;15(3):379–91.
https://doi.org/10.1158/1535-7163.MCT-15-0651
.
5. Kolesnikov N, Hastings E, Keays M, et al. ArrayExpress update—simplifying data submissions. Nucleic Acids Res. 2015;43:D1113–6.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献